First prospective, single-arm, multicenter study to evaluate safety and efficacy of the overall thrombectomy system -iNedit, iNdeep, and iNtercept- for acute ischemic stroke. Rationale beyond the study
Primary efficacy endpoint: expanded treatment in cerebral infarction score (eTICI) ≥2b revascularization within ≤ 3 stent retriever passes. Primary safety endpoint: monitoring serious adverse events within 24 h post-intervention and all-cause mortality at 90 days.
Authors
- Luís San Román (ORCID: https://orcid.org/0000-0003-0735-4373)
- Lluís Duocastella
- Laura Domingo‐Rodriguez
- Sara Pich
- Laura Ludovica Gramegna (ORCID: https://orcid.org/0000-0002-9192-5994)
- Juan Macho (ORCID: https://orcid.org/0000-0002-8417-7094)
- Marta Duran
Institutions
- Vall d'Hebron Institut de Recerca (ES)
- Hospital Clínic de Barcelona (ES)
- Barcelona IVI Clinic (ES)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2025-03-05
- DOI
- https://doi.org/10.3389/fneur.2025.1537008
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00